Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. An infectious disease expert panel cautions against routine use of bamlanivimab (Eli Lilly) and notes that remdesivir (Veklury) can shorten the clinical course of COVID-19 — which could be critical as “as hospitals fill up” across the United States. The group also said the…